nach oben

Erschienen in:

18.02.2021 | letter to the editors

Sampling site matters when testing for COVID-19 after total laryngectomy: a case report

verfasst von: Johannes Schmid, MD, PhD, Jürgen Prattes, MD, Ann-Katrin Kaufmann-Bühler, MD, Jakob M. Riedl, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2021

Einloggen, um Zugang zu erhalten

Auszug

Patients after total laryngectomy are special in many respects, including the management in the current pandemic of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we report the case of a patient who had undergone total laryngectomy due to laryngeal carcinoma with discordant SARS-CoV‑2 test results performed in nasopharyngeal and tracheal samples. …

Vorheriger Artikel Is there an association between hypothyroidism and COVID 19?

Nächster Artikel MUW researcher of the month

Ojha V, Mani A, Pandey NN, Sharma S, Kumar S. CT in coronavirus disease 2019 (COVID-19): a systematic review of chest CT findings in 4410 adult patients. Eur Radiol. 2020;30:6129–38. https://doi.org/10.1007/s00330-020-06975-7.CrossRefPubMed

Hennessy M, Bann DV, Patel VA, Saadi R, Krempl GA, Deschler DG, et al. Commentary on the management of total laryngectomy patients during the COVID-19 pandemic. Head Neck. 2020;42:1137–43. https://doi.org/10.1002/hed.26183.CrossRefPubMedPubMedCentral

Paderno A, Fior M, Berretti G, Del Bon F, Schreiber A, Grammatica A. COVID-19 and total laryngectomy—A report of two cases. Ann Otol Rhinol Laryngol. 2020; https://doi.org/10.1177/0003489420935500.CrossRefPubMed

Patel TR, Teitcher JE, Tajudeen BA, Revenaugh PC. Disparate nasopharyngeal and tracheal COVID-19 diagnostic test results in a patient with a total laryngectomy. Otolaryngol Head Neck Surg. 2020;163:710–1. https://doi.org/10.1177/0194599820933605.CrossRefPubMed

Kinloch NN, Ritchie G, Brumme CJ, Dong W, Dong W, Lawson T, et al. Suboptimal biological sampling as a probable cause of false-negative COVID-19 diagnostic test results. J Infect Dis. 2020;222:899–902. https://doi.org/10.1093/infdis/jiaa370.CrossRefPubMedPubMedCentral

Titel: Sampling site matters when testing for COVID-19 after total laryngectomy: a case report
verfasst von: Johannes Schmid, MD, PhD
Jürgen Prattes, MD
Ann-Katrin Kaufmann-Bühler, MD
Jakob M. Riedl, MD
Publikationsdatum: 18.02.2021
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 7-8/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-021-01826-x

A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center

short report

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

Open Access
case report

Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic

original article

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort

Open Access
original article

Sex and age differences in COVID-19 mortality in Europe

short report

Veranstaltungstipps:

mitteilungen der gesellschaft der ärzte in wien

Springer Medizin Österreich

Sampling site matters when testing for COVID-19 after total laryngectomy: a case report

Auszug

Weitere Artikel der Ausgabe 7-8/2021

A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort

Sex and age differences in COVID-19 mortality in Europe

Veranstaltungstipps:

Springer Medizin Österreich

Auszug

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

A retrospective comparison between influenza and COVID-19-associated ARDS in a Croatian tertiary care center

COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease

Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic

6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort

Sex and age differences in COVID-19 mortality in Europe

Veranstaltungstipps: